Cite

HARVARD Citation

    Kiyota, N. et al. (n.d.). Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine‐refractory differentiated thyroid cancer. Cancer science. 106 (12), pp. 1714-1721. [Online]. 
  
Back to record